NCT06964867 Effectiveness of Multimedia Health Education to Reduce Anxiety in Patients With Vitreous Floaters
| NCT ID | NCT06964867 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Changzhou No.2 People's Hospital |
| Condition | Vitreous Floaters |
| Study Type | INTERVENTIONAL |
| Enrollment | 300 participants |
| Start Date | 2023-12-01 |
| Primary Completion | 2025-06-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 300 participants in total. It began in 2023-12-01 with a primary completion date of 2025-06-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The patients with vitreous floaters were randomly divided into to groups after excluding the possibility of coexisting ocular pathologies potentially confounding visual symptoms or vitreoretinal anatomy. The control group performed conventional oral education. The experimental group conducted multimedia health education activities on the basis of conventional oral education. Their VRQoL (Visual Function Questionnaire-25, VFQ-25) and anxiety status (State-Trait Anxiety Inventory, STAI) were evaluated before education and at the final follow-up. The demographic and clinical characteristics (gender, age, eduaction, duration of vitreous floaters, comorbidities and so on) were collected.
Eligibility Criteria
Inclusion Criteria: 1. Clinical diagnosis of vitreous floaters; 2. Be able to complete questionnaires. Exclusion Criteria: 1. Secondary VF requiring surgical intervention; 2. Coexisting ocular pathologies potentially confounding vitreoretinal anatomy; 3. History of vitreoretinal surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06964867 clinical trial?
This trial is open to participants of all sexes, studying Vitreous Floaters. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06964867 currently recruiting?
Yes, NCT06964867 is actively recruiting participants. Contact the research team at fengqing20001128@163.com for enrollment information.
Where is the NCT06964867 trial being conducted?
This trial is being conducted at Changzhou, China.
Who is sponsoring the NCT06964867 clinical trial?
NCT06964867 is sponsored by Changzhou No.2 People's Hospital. The trial plans to enroll 300 participants.